Muscle Pharm Corp. (MSLP)
-OTC Markets 10.60 
0.05(0.47%) 9:39AM EDT
| Prev Close: | 10.55 |
|---|
| Open: | 10.50 |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 16.00 |
|---|
| Beta: | 2.89 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 10.50 - 10.60 |
|---|
| 52wk Range: | 3.90 - 12.47 |
|---|
| Volume: | 43,261 |
|---|
| Avg Vol (3m): | 68,644 |
|---|
| Market Cap: | 75.26M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -4.82 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Why I'm Betting Big On MusclePharmat Seeking Alpha(Tue, Jun 18)
- MusclePharm Executive V.P. and Co-Founder, Cory Gregory, Featured on Cover of July Edition of Fitness Rx MagazineMarketwired(Thu, May 30)
- MUSCLEPHARM CORP FinancialsEDGAR Online Financials(Tue, May 21)
- MusclePharm to Present at B. Riley & Co. 14th Annual Investor Conference on Monday, May 20th at 1:00 pm PDTMarketwired(Mon, May 20)
- New Stock Coverage: MusclePharm Can Bulk Up Your Portfolioat Minyanville(Mon, May 20)
- Coverage initiated on Muscle Pharm by Ascendiant Capital MarketsBriefing.com(Sun, May 19)
- MusclePharm Corp's CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Wed, May 15)
- MusclePharm Reports Its First Quarterly Positive Adjusted Operating Income of $2.8 MillionMarketwired(Wed, May 15)
- MUSCLEPHARM CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Wed, May 15)
- MUSCLEPHARM CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed, May 15)
- MusclePharm to Release 1st Quarter Earnings and Host Conference Call on May 15thMarketwired(Thu, May 9)
- Former Office Depot Executive Named MusclePharm COOMarketwired(Thu, May 2)
- MUSCLEPHARM CORP Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Wed, May 1)
- Muscle Pharm Will 'Bulk Up' Your Returnsat Seeking Alpha(Thu, Apr 25)
- RedChip Emerging Growth Showcase to Feature More Than 25 CompaniesGlobeNewswire(Tue, Apr 23)
Reports
- No Reports available for MSLP at this time.
Key Statistics
| Forward P/E (1 yr): | 12.62 |
|---|
| P/S (ttm): | 1.03 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.92 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.07 |
|---|
| Mean Recommendation*: | 1.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
MusclePharm Corporation develops, manufactures, and markets sports nutrition products in the United States and internationally. It offers Amino 1, a hydration sports recovery drink; Armor-V Advanced Multi Nutrient Complex; Assault for enhancing fo...
View More